Bio-Rad Laboratories, Inc. BIO.B Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $510.4M-4.1% | $532.2M+8.3% | $491.5M-8.0% | $534.2M+3.7% | $515.3M+13.2% | ||
| $153.2M-2.8% | $157.6M+1.9% | $154.7M-5.2% | $163.2M+2.1% | $159.8M-3.5% | ||
| $742M+10.9% | $669.3M-11.2% | $753.4M-18.9% | $928.7M-9.3% | $1.02B-19.8% | ||
| $767.5M-3.3% | $793.6M-6.8% | $851.7M-16.1% | $1.02B+7.3% | $945.7M-14.5% | ||
| —— | —— | —— | —— | —— | ||
| -$285.8M-50.7% | -$189.7M-2.0% | -$186M+6.4% | -$198.7M-74.0% | -$114.2M+28.7% | ||
| $241.4M-18.3% | $295.5M0.0% | $295.5M-13.1% | $340M+13.0% | $300.8M+47.7% | ||
| $500K0.0% | $500K+66.7% | $300K-25.0% | $400K+33.3% | $300K-25.0% | ||
| $14.9M-5.7% | $15.8M0.0% | $15.8M-9.7% | $17.5M-2.8% | $18M-6.3% | ||
| -$232.8M+18.7% | -$286.5M+8.4% | -$312.7M+12.2% | -$356.2M-12.5% | -$316.5M-44.7% | ||
| —— | —— | —— | -$15.3M-426% | $4.7M-48.9% | ||
| -$14.1M-133% | $42.4M+403% | -$14M+61.1% | -$36M— | —— | ||
| $46.8M+0.4% | $46.6M+0.4% | $46.4M+0.2% | $46.3M0.0% | $46.3M-0.4% | ||
| $66.5M+4.9% | $63.4M-20.6% | $79.8M-22.7% | $103.3M-0.2% | $103.5M+4.1% | ||
| $2.09B+1.4% | $2.06B+1.0% | $2.04B+3.6% | $1.97B-0.9% | $1.99B-3.5% | ||
| —— | —— | —— | —— | —— | ||
| $2.63B-1.0% | $2.66B+2.5% | $2.59B-0.1% | $2.59B+1.5% | $2.55B+0.1% | ||
| $98M+21.0% | $81M-0.9% | $81.7M-2.7% | $84M-3.0% | $86.6M+0.6% | ||
| —— | -$38.1M-61.8% | -$23.55M-162% | -$9M-262% | $5.55M-72.4% | ||
| $60.2M-2.9% | $62M-30.2% | $88.8M-24.8% | $118.1M-19.5% | $146.7M-26.4% | ||
| $767.5M-3.3% | $793.6M-6.8% | $851.7M-16.1% | $1.02B+7.3% | $945.7M-14.5% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | $15.8M-5.1% | $16.65M-4.9% | $17.5M-4.6% | $18.35M-4.4% | ||
| —— | -$16.9M-62.9% | -$10.38M-169% | -$3.85M-244% | $2.68M-70.9% | ||
| —— | $46.6M+0.1% | $46.58M+0.1% | $46.55M+0.1% | $46.53M+0.1% | ||
| $66.5M+4.9% | $63.4M-20.6% | $79.8M-22.7% | $103.3M-0.2% | $103.5M+4.1% | ||
| $357.2M-4.6% | $374.6M+11.2% | $336.8M-9.2% | $371M+4.4% | $355.5M+22.8% | ||
| $357.2M-4.6% | $374.6M+11.2% | $336.8M-9.2% | $371M+4.4% | $355.5M+22.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Bio-Rad Laboratories, Inc. generate?
- Bio-Rad Laboratories, Inc. (BIO.B) generated $510.4M in operating cash flow over the trailing twelve months.
- What is Bio-Rad Laboratories, Inc.'s free cash flow?
- After $153.2M of capital expenditures, Bio-Rad Laboratories, Inc.'s free cash flow was $357.2M over the trailing twelve months, up 0.5% year over year.
- Where does Bio-Rad Laboratories, Inc.'s cash flow data come from?
- Every line is extracted from Bio-Rad Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
